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Hepadnaviruses establish chronic liver infections, but the mechanisms of persistence and immune evasion are poorly understood. We
previously found that the duck hepatitis B virus (DHBV) and hepatitis B virus reverse transcriptases (P protein) unexpectedly accumulate in the
cytoplasm where they could affect function(s) beyond viral DNA synthesis, such as gene expression. Therefore, we measured effects of DHBV P
on gene expression from reporter constructs and the viral genome. P reduced reporter expression at the mRNA level to ∼30–40%, independent of
reporter tested. Accumulation of the viral pregenomic RNA from its native promoter was suppressed three-to four-fold by P, and accumulation of
the capsid protein and intracellular core particles was similarly suppressed because the pregenomic RNA encodes the capsid protein. Therefore,
suppression of the pregenomic RNA by DHBV P creates a negative feedback loop to limit viral antigen accumulation and replication, possibly
contributing to maintenance of chronic infection.
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Hepadnaviruses are hepatotropic, partially double-stranded
DNA viruses that infect birds, rodents and higher primates
(Ganem and Schneider, 2001). Hepatitis B virus (HBV) is a
major human pathogen, infecting over 350 million people
worldwide. It causes hepatitis, hepatic fibrosis and cirrhosis and
can induce hepatocellular carcinoma (Ganem and Prince, 2004).
Duck hepatitis B virus (DHBV) infects pekin ducks and is a
common model for HBV.
Hepadnaviruses establish persistent liver infections that can
last for the lifetime of the host, and persistence is maintained by
ongoing viral gene expression and replication. Surprisingly, the
viruses have remarkably little impact on function of the infected
cell (Wieland and Chisari, 2005). Inherent to this replication
strategy is the ability to evade the immune system for indefinite⁎ Corresponding author. Department of Molecular Microbiology and
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doi:10.1016/j.virol.2006.02.026periods, but the mechanism(s) by which the hepadnaviruses
avoid immune-mediated clearance are incompletely understood
(Rehermann and Nascimbeni, 2005).
Hepadnaviruses replicate by reverse transcription within
subviral core particles in the cytoplasm (Summers and Mason,
1982). Core particles are formed by the core protein (C) and
contain the RNA form of the genome (the pregenomic RNA,
pgRNA) and the virally encoded reverse transcriptase (P). In
addition to its role in viral DNA replication, the pgRNA is a
bicistronic mRNA that encodes C and P, with the P open reading
frame (ORF) in the downstream position. Downstream ORFs on
eukaryotic mRNAs are generally very poorly translated (if they
are translated at all), but we found that translation of the DHBV
P is relatively rapid (Yao and Tavis, 2003) and occurs through a
highly unusual ribosomal “shunt” (Sen et al., 2004). Although
the only known function of P is to synthesize DNA within the
core particles, both DHBV and HBV P unexpectedly accumu-
late to appreciable levels in the cytoplasm outside of core
particles (Yao et al., 2000; Cao and Tavis, 2004). Furthermore,
accumulation of cytoplasmic DHBV P is regulated at the
translational (Yao et al., 2003) and post-translational levels (Yao
and Tavis, 2003).
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not without cost to the virus because both humoral and cellular
immune responses against P develop about as rapidly and
efficiently as they do against C, a major viral structural protein
(Kann et al., 1993; Weimer et al., 1990; Rehermann et al.,
1995). Given the unusual effort the virus puts into producing a
large excess of P over what is needed for DNA synthesis and the
immunological cost associated with this effort, we hypothesized
that the cytoplasmic form of P may have an important role in
viral replication beyond synthesizing progeny DNA, possibly
assisting immune evasion or optimizing the cell for viral
replication (Yao et al., 2000). Therefore, we began our search
for a function of cytoplasmic P by assessing the effect of DHBV
P on gene expression in cells.
Results
Construction of P expression vectors
The two viral surface glycoproteins (L and S) are encoded in
an alternate reading frame within the P ORF. In addition, an
unusual ORF is found near the 3′ end of the DHBV P gene that
could encode a small protein proposed to be analogous to the X
protein found in the mammalian hepadnaviruses (Chang et al.,
2001). Therefore, to ensure that P was the only protein that
could be expressed from the P expression vectors employed, we
ablated expression of L, S and the potential X-like protein with
mutations that were silent in the P ORF in all constructs. All
three of these mutations were previously demonstrated to block
synthesis of their respective target proteins (Chang et al., 2001;
Ishikawa and Ganem, 1995).
To create a P-deficient negative control, we had to mutate the
first five AUG codons in the P ORF plus create a frameshift at
codon 374 before P fragments were no longer detectable by
Western or immunofluorescence analyses (data not shown). The
unusual tenacity of the DHBV P ORF in expressing P fragments
from a mutated gene may be related to its expression through a
ribosomal shunt rather than through standard ribosomal
scanning (Sen et al., 2004). Validating that fragments of P
were not expressed from this negative control construct was key
to this study because many of the constructs that expressed
fragments of P retained residual effects on reporter gene
expression in pilot experiments (data not shown).
P suppresses reporter gene expression
A plausible mechanism for cytoplasmic DHBV P to affect
cellular or viral function would be to modulate cytoplasmic
signaling cascades, leading to altered nuclear transcription.
Therefore, to determine if cytoplasmic P can alter gene
expression or cellular viability, we performed co-transfection
experiments with various reporter genes. LMH cells were co-
transfected with β-galactosidase expression vectors plus
pCMV-DPol, pCMV-DPol− (genetic knockout of P),
pCDNA3.1 (empty vector negative control), pCMV-CAT
(expresses chloramphenicol acetyl transferase as an irrelevant
protein control) or pCMV-HABIK (positive control thatexpresses BIK and hence induces apoptosis). Three β-
galactosidase reporter constructs with different promoters
were employed: pSBH1-lacZ contains the SV40 early promoter,
pCMV-MP1-lacZ contains the CMV immediate-early promoter,
and pRSV-lacZ contains the RSV long terminal repeat
promoter. Two days post-transfection, lysates were prepared
by repeatedly freezing and thawing cells in PBS. β-galactosi-
dase activity in the lysates was measured, and activity levels
were normalized for total protein in the lysates. For the SV40-
and RSV-driven β-galactosidase reporters, high level activity
was observed with pCDNA3.1, pCMV-CAT and pCMV-DPol−
constructs, essentially no activity was observed with pCMV-
HABIK because the transfected cells had died, and ∼30–40%
of the activity observed in pCDNA3.1 was observed with
pCMV-DPol (Fig. 1A). A similar pattern was seen when β-
galactosidase was expressed from the CMV promoter, except
that suppression by P (to ∼60% of the pCDNA3.1 control) was
less than was observed with the other reporters. The suppression
of β-galactosidase activity in the presence of P was highly
statistically significant in all cases by the one-way ANOVA post
hoc test (P < 0.001).
Similar suppression of reporter gene expression by DHBV P
was observed when the luciferase reporter gene was driven by
the SV40 promoter (Fig. 1A) and when the GFP reporter was
driven by the CMV promoter (Fig. 4B), although again the
degree of suppression observed from the SV40 promoter was
greater than from the CMV promoter. Dose-escalation experi-
ments in which increasing amounts of pCMV-DPol were co-
transfected with pCMV-MP1-lacZ indicated that suppression of
β-galactosidase activity was dependent upon the amount of
pCMV-DPol transfected, and Western blots of these lysates
confirmed that P levels accumulated proportionally to the
amount of pCMV-DPol plasmid in the transfection (Fig. 1B).
Therefore, P reduced β-galactosidase activity expressed
from three different promoters and also suppressed the activity
of three different reporter genes. The degree of suppression
ranged between 2- and 4-fold for the various reporter constructs.
Reporter gene suppression is due to reduced mRNA
accumulation
To determine if suppression of β-galactosidase activity
occurred at the RNA or protein level, we performed a co-
transfection experiment with pSBH1-lacZ and measured β-
galactosidase activity and lacZ RNA levels. Two days post-
transfection, duplicate plates of cells were lysed and either
whole-cell RNA was isolated or a protein extract was prepared
by freeze–thaw lysis to measure β-galactosidase activity. A
close correlation was observed between lacZ mRNA levels and
β-galactosidase activity (Fig. 2). The small differences between
mRNA levels and activity were not significant (P > 0.05),
indicating that the suppression of reporter gene activity by
DHBV P occurred at the RNA level.
We next determined if reduction of reporter gene mRNA
levels was due to death of a proportion of the transfected cells, to
reduced transfection efficiency and/or to reduced mRNA levels
in co-transfected cells. Three plates of LMH cells were co-
Fig. 1. DHBV P suppresses reporter gene activity from co-transfected plasmids. (A) Suppression of reporter activity from a variety of reporter constructs. LMH cells
were co-transfected with a β-galactosidase reporter driven by the CMV, RSVor SV40 promoter or an SV40-driven luciferase reporter plus the indicated test plasmids.
β-galactosidase or luciferase activity was measured in cellular lysates 2 days post-transfection. Values are averages from six independent plates from two transfections;
error bars represent the standard deviation. * indicates P < 0.001 (post hoc test). (B) Dose dependence of suppression. Duplicate plates of LMH cells were co-
transfected with varying amounts of pCMV-DPol and a CMV-driven β-galactosidase reporter. Two days post-transfection, β-galactosidase activity was measured in
lysates from one plate and P levels were determined by Western blotting in lysates from the other plate.
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pCDNA3.1 or pCMV-HABIK, and β-galactosidase activity
was determined on day 2 post-transfection. The first plate for
each co-transfection was lysed, and total β-galactosidase
activity was measured in the lysate. Co-transfection with
pCDNA-HABIK yielded essentially noβ-galactosidase activity,
and co-transfection with pCMV-DPol yielded only 28% of the
activity found for the pCDNA3.1 empty vector control (Fig.
3A). The remaining two plates for each co-transfection were
fixed with paraformaldehyde and stained in situ with X-gal for
β-galactosidase activity. One plate for each co-transfection was
developed for 5 min, and the other was developed for 120 min.
Following termination of color development, blue cells in 12
arbitrarily chosen fields distributed evenly across the plate werecounted. Cells were scored as blue regardless of the intensity of
the staining, and counting was done blinded to the identity of the
plasmids transfected. When the plates were stained with X-gal
for 5 min, the pCMV-DPol co-transfection had roughly 35% as
many blue cells as did the pCDNA3.1 co-transfection (Fig. 3B).
However, when color development was allowed to reach
saturation (2 h staining), the number of cells with detectable
blue staining was essentially the same in the pCMV-DPol and
pCDNA3.1 co-transfections. Therefore, there was no difference
in the transfection efficiency or cell viability between cells
transfected with pCMV-DPol and pCDNA3.1.
These results were extended by co-transfecting LMH cells
with pCMV-GFP and various test plasmids and performing flow
cytometry on the cells at days 1, 2 and 3 post-transfection. The
Fig. 3. P does not reduce the number of transfected cells or suppress co-
transfection efficiency. LMH cells were co-transfected in triplicate with the
indicated plasmids plus the SV40-driven β-galactosidase reporter. At 2 days
post-transfection, one plate was lysed for measurement of total β-galactosidase
activity. The remaining plates for each co-transfection were fixed, stained with
X-Gal for β-galactosidase activity in situ for 5 min or 2 h and cells with
detectable blue staining were counted. (A) β-galactosidase activity in lysates.
(B) In situ β-galactosidase activity.
Fig. 2. P suppresses reporter gene mRNA accumulation. LMH cells were co-
transfected with the indicated plasmids plus the SV40-driven β-galactosidase
reporter. At day 2 post-transfection, β-galactosidase activity and lacZ mRNA
levels were measured in lysates from duplicate plates. All values were
normalized to levels found in the empty vector control. (A) Relative mRNA
levels compared to relative β-galactosidase activity. (B) A representative
Northern blot quantified for panel A. The ethidium-bromide-stained 18S rRNA
band prior to transfer is shown as a loading control.
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when the reporter construct was co-transfected with pCMV-
DPol than with pCDNA3.1, pCMV-CAT or pCMV-DPol− (Fig.
4A), but this difference was primarily due to a modest decrease
in the mean fluorescence intensity of the cells, causing some of
the cells to drop below the gate established for GFP positivity
(Fig. 4B).
Therefore, co-expression of P in cells with the reporter
constructs reduced expression of the reporter genes by reducing
the average amount of reporter gene mRNA per cell rather than
by reducing transfection efficiency or killing a percentage of the
co-transfected cells.
Accumulation of the pgRNA is negatively regulated by P
The non-physiological reporter constructs in the previous
experiments were used as a primary screen to determine if P
could affect gene expression. To determine if P had a similar
effect on a physiological target, we measured its effect on
pgRNA accumulation transcribed from the natural DHBV
promoter.First, we compared pgRNA accumulation from a wild-type
overlength pgRNA expression vector (D1.5G) to accumulation
fromD1.5Gderivatives inwhich expression of L, S and theX-like
protein (D1.5G-LSX−) or L, S, X-like and P (D1.5G-PLSX−)
was ablated. At days 1, 2 and 3 post-transfection, cells were
harvested and pgRNA levels were measured by Northern
analysis (Fig. 5A). Ablation of surface antigen and X-like
protein expression had no effect on pgRNA accumulation.
However, ablation of P expression increased pgRNA accumu-
lation, with the magnitude of the increase becoming greater with
time. To exclude the possibility that increased pgRNA
accumulation in the P-deficient construct may have been due
to failure to encapsidate pgRNA into core particles (where it
would be converted to DNA and hence not be detected by
Northern analysis), we assessed pgRNA levels from constructs
in which encapsidation was blocked by inserting the loop5,6
mutations into the encapsidation signal, ϵ (Pollack and Ganem,
1994). Ablating P expression in the loop5,6 background (D1.5G-
loop5,6-PLSX−) increased pgRNA expression 3- to 4-fold
relative to D1.5G-loop5,6 and D1.5G-loop5,6-LSX− (Fig. 5B;
P ≤ 0.001 in both cases). Therefore, ablating P expression
increased pgRNA accumulation when the pgRNA was tran-
scribed from its natural promoter.
Fig. 4. Flow cytometry of co-transfected cells. LMH cells were co-transfected in
triplicate with the indicated plasmids plus the CMV-driven GFP reporter. At
days 1, 2 and 3 post-transfection, the cells were released from the plates by
trypsinization and examined for GFP fluorescence by flow cytometry. (A)
Percent GFP-expressing cells. (B) Mean fluorescence intensity of transfected
cells.
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can occur in cis or trans, we employed D1.5G-PLSX− as a P-
deficient pgRNA reporter. D1.5G-PLSX− was co-transfected
with pCMV-CAT, pCMV-DPol or pCMV-DPol− and pgRNA
levels were measured by Northern analysis (Fig. 5C). pCMV-
CAT and pCMV-DPol− had no effect on pgRNA levels,
whereas co-transfection with pCMV-DPol reduced pgRNA
accumulation by 60–70% relative to pCMV-DPol− (P < 0.001).
The mRNA expressed from pCMV-DPol was also detected in
these Northern blots (Fig. 5D) because the probe included P
sequences. This P mRNA accumulated to a 2- to 3-fold lower
level from pCMV-DPol than from pCMV-DPol−, indicating
that mRNA accumulation from this construct was also subject
to suppression by P. Therefore, P can suppress mRNA
accumulation both in cis and trans.
C accumulation is suppressed in parallel with the pgRNA
The pgRNA is a bicstronic mRNA that encodes both P and
the viral capsid protein, C. To determine if suppression of the
pgRNA by P led to a reduction in C accumulation, LMH cells
were co-transfected with D1.5G-PLSX− (as a C reporter) plus
pCMV-CAT, pCMV-DPol or pCMV-DPol− and C levels weremeasured on day 2 post-transfection by Western analysis (Fig.
6A). C levels were reduced in cells transfected with pCMV-
DPol by roughly 2-fold relative to cells transfected with either
pCMV-CAT or pCMV-DPol−. Similar results were observed
when P expression was manipulated in cis from the viral
genome. Cells transfected with D1.5G-PLSX− produced about
1.8-fold more C than did cells transfected with D1.5G or
D1.5G-LSX− (Fig. 6B). Finally, very similar results were
observed when C levels in assembled capsids instead of in total
cell lysates were measured (data not shown). Therefore,
suppression of pgRNA accumulation by P led to a
corresponding reduction in accumulation of C.
Discussion
These data indicate that DHBV P can modestly reduce
accumulation of some mRNAs in LMH cells. Although the
effect on the artificial reporter constructs is only∼2- to 3-fold, it
is highly statistically significant and is larger than the 1.5- to 2-
fold cutoff values used in most microarray studies to define
genes with altered expression levels. More importantly, the
pgRNA is a physiologically relevant target of suppression, and
in this case, the suppression was larger, ranging from 3- to 4-
fold (Fig. 5). This reduction would repress virion production
because the pgRNA is the RNA form of the genome and the
mRNA for P and C. Therefore, expression of P appears to
establish a negative feedback loop that restricts viral replication.
Suppressing pgRNA accumulation could also moderate
immune responses to infected cells because reducing pgRNA
accumulation led to a reduction in C accumulation (Fig. 6). P
accumulation would be predicted to be similarly reduced
because it is also translated from the pgRNA, but this could not
be measured because P levels must be manipulated to alter
pgRNA accumulation in these experiments. An example of
reducing antiviral immune responses through negative regula-
tion of viral gene expression was recently provided with SV40,
where micro-RNA repression of T antigen accumulation to a
degree similar to what we observe here led to reduced CD8+ T
cell responses against infected cells (Sullivan et al., 2005).
Restricting production of DHBV P and C would reduce the
immune pressure on infected cells by reducing antigen load, and
reducing or delaying antiviral immune responses could provide
a growth advantage to the virus to offset the growth defect from
reduced virion production. To yield a net benefit to the virus, the
growth advantage from reduced immune pressure in infected
ducks would have to be only slightly larger than the growth
deficit from suppressing virion production from infected cells.
For example, a mutant DHBV strain with a growth deficit of just
33% was rapidly overgrown when in competition with wild-
type virus, even when the titer of the mutant virus in the
inoculum was 1000-fold higher than that of the wild-type virus
(Zhang and Summers, 2000).
Therefore, although the effect of P on pgRNA accumulation
is modest, it may well be biologically significant.
Non-physiological effects can be observed in co-transfection
experiments in which proteins are overexpressed. Overexpres-
sion may have affected our experiments employing pCMV-
Fig. 5. P reduces pgRNA accumulation. (A) Ablating P expression from the DHBV genome increases pgRNA accumulation. The indicated D1.5G derivatives were
transfected into LMH cells, and 1, 2, and 3 days later, pgRNA levels were measured by Northern analysis. Statistical significance of key comparisons is indicated (post
hoc test). Note that the difference in significance levels between A and B or C is due to fewer replicates of the experiment in panel A. (B) Failure of encapsidation is not
the reason for increased pgRNA accumulation in the absence of P. LMH cells were transfected with the indicated encapsidation-deficient pgRNA expression
constructs, and 2 days post-transfection, pgRNA levels were measured by Northern analysis. (C) P can suppress pgRNA accumulation in trans. D1.5G-PLSX− was
co-transfected with pCMV-CAT, pCMV-DPol or pCMV-DPol−, and 2 days later, cells were lysed and pgRNA levels were measured by Northern blot analysis. (D) A
representative Northern blot for panels A–C. The ethidium-bromide-stained 18S rRNA band prior to transfer is shown as a loading control.
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effects of P for two reasons. First, pCMV-DPol produces only
about 2-fold more P than the physiological levels produced
from the genomic expression vector D1.5G (data not shown).
Second, the suppressive effect of P on the pgRNAwas observed
at physiological P levels when P expression was manipulated
genetically in the context of the genomic expression vector
(Fig. 5A).
The suppressive effect of P on mRNA accumulation may act
at the transcriptional level because the suppression observed
when the SV40 or RSV LTR promoters were used to drive the
lacZ gene was larger than when the same reporter gene was
driven by the CMV promoter. Furthermore, substituting the
luciferase reporter gene for the β-galactosidase gene down-
stream of the SV40 promoter did not alter the suppressive effect,
implying that the coding region of the reporter construct was not
the direct target of suppression. Furthermore, the only common
feature of the mRNAs produced from the reporter constructsemployed is that they are unspliced, and inserting an artificial
intron into the SV40-driven lacZ expression construct did not
relieve suppression by P (data not shown).
Almost all DHBV P in cells is cytoplasmic, and only trace
levels of P can be detected in the nucleus (Yao et al., 2000).
Therefore, P probably exerts its suppressive effect by interfering
with cytoplasmic components of one or more cellular signaling
pathways rather than by directly binding to DNA or
transcription complexes. We have shown that DHBV and
HBV P bind to membrane-containing cytoplasmic structures,
including the endoplasmic reticulum (Yao et al., 2000; Cao and
Tavis, 2004), providing ample opportunity for P to modulate
cytoplasmic signaling. However, no such effect has yet been
directly demonstrated.
The mammalian hepadnaviruses encode the X protein, a
weak transcriptional activator that is essential for establishment
of infection in animals and may augment development of
hepatocellular carcinoma (Bouchard and Schneider, 2004). The
Fig. 6. Suppression of pgRNA levels by P reduces C accumulation. (A) P can
suppress C accumulation in trans. D1.5G-PLSX− was co-transfected with
pCMV-CAT, pCMV-DPol or pCMV-DPol− in LMH cells. Two days later, cells
were lysed and C levels were measured by Northern blot analysis. PBS, cells
transfected with pBS as an empty vector control for D1.5G. (B) Ablating P
expression from the genome increases C accumulation. The indicated D1.5G
derivatives were transfected into LMH cells, and 2 days later, C levels were
measured by Western analysis. PBS, cells transfected with pBS as an empty
vector control for D1.5G.
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because they do not have an analogous ORF. An X-like protein
could be produced by non-canonical translation mechanisms
(Chang et al., 2001), but ablation of this unusual ORF has no
effect on viral replication in ducks (Meier et al., 2003).
Therefore, even if the DHBV X-like protein is produced, it does
not serve the same role in infection as does HBV X. Our data
indicate that cytoplasmic DHBV P could provide regulatory
functions analogous to those of X, but P and X would not
employ an identical mechanism because P suppresses mRNA
levels, whereas X elevates them. The opposing modulation of
mRNA levels by P and X does not preclude the two proteins
having a common effect on viral infection because the unknown
cellular pathway(s) that DHBV P modulates could activate
cellular genes that have not yet been examined or suppress
cellular genes that regulate DHBV replication. Our inability to
demonstrate mRNA suppression by HBV P (data not shown) is
consistent with this conjecture. Therefore, the hypothesis that
DHBV P may provide regulatory functions analogous to those
of HBV X is intriguing but as-yet untested.
The negative effect of P on mRNA accumulation demon-
strated here may be exclusively directed towards the pgRNA
during infection. In this case, its net biological effect would be
to fine-tune viral replication in infected cells, possibly to limit
viral impact on the infected hepatocytes or reduce antigen
presentation. Alternatively, the effect of P on mRNA accumu-
lation could also be directed toward one or more unidentified
cellular genes. In this case, the regulatory activity of P could
have much larger effects on viral replication and/or immune
evasion. These possibilities are under investigation.
Materials and methods
Virus and DNA constructs
These studies employed DHBV3 (Sprengel et al., 1985).
pCMV-DPol (DPol) is an expression vector for DHBV P in
which expression of the surface glycoproteins (L and S) [L− and
S−, (Ishikawa and Ganem, 1995)] and putative X-like protein
(Chang et al., 2001) has been ablated by mutations that are silent
in the overlapping P ORF. pCMV-DPol− (DPol−) is pCMV-
DPol in which P protein expression has been ablated by
mutating the first five AUG codons and creating a frameshift at
the KpnI site (codon 374). D1.5G is a wild-type overlength
DHBV3 pgRNA expression vector. D1.5G-LSX− is D1.5G in
which expression of the L, S and putative X-like proteins has
been ablated. D1.5G-PLSX− is D1.5G-LSX− in which P
expression has been ablated with the same mutations employed
in pCMV-DPol−. D1.5G-loop5,6 is an encapsidation-deficient
D1.5G derivative containing T2591C and G2592A mutations in
the 5′ copy of the pgRNA encapsidation signal, ϵ (Pollack and
Ganem, 1994). D1.5G-loop5,6-LSX− is D1.5G-loop5,6 in
which expression of the L, S and putative X-like proteins has
been ablated. D1.5G-loop5,6-PLSX− is D1.5G-loop5,6-LSX−
in which P expression has been ablated.
pCMV-MP1-lacZ encodes the lacZ gene downstream of the
human cytomegalovirus immediate-early promoter. pSBH1-
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early promoter. pRSV-lacZ encodes the lacZ gene downstream
of the Rous sarcoma virus LTR promoter. pCMV-GFP encodes
the green fluorescent protein downstream of the CMV promoter.
pSV40-luc encodes the luciferase gene downstream of the SV40
early promoter. pCMV-CAT (CAT) encodes the choramphena-
col acetyl transferase gene downstream of the CMV promoter.
pCMV-HABIK (BIK) encodes an HA-epitope-tagged version of
the BIK apoptosis-inducing gene downstream of the CMV
promoter (Yasuda and Chinnadurai, 2000). All CMV-driven
constructs are derivatives of pCDNA3.1 (Invitrogen).
Cell lines and transfection
LMH cells (Condreay et al., 1990) are chicken hepatoma
cells that produce infectious DHBV when transfected with
pgRNA expression vectors such as D1.5G. LMH cells were
transfected with a 1:1 ratio of reporter and test plasmids
employing FuGENE (Roche Diagnostics) according to the
manufacturer's instructions.
β-galactosidase assays
Solution assay
Lysates of transfected cells were prepared by scraping cells
into PBS followed by three freeze–thaw cycles. β-galactosidase
levels were measured by adding cell lysate to 0.1 M sodium
phosphate (pH 7.5) to a total volume of 150 μl. An equal
volume of substrate mixture containing 2 mM MgCl2 and
1.76 mg/ml O-nitrophenyl-β-D-galactopyranoside in 0.1 M
sodium phosphate buffer (pH 7.5) was added to the diluted cell
lysate, and the tubes were incubated at 30 °C for 30 min. The
reaction was stopped by adding 0.5 ml 1 M sodium bicarbonate,
and the optical density was read at 420 nm; all results were
normalized for total protein concentration in the lysates as
determined by the BioRad Protein Assay (BioRad).
In situ assay
Cell monolayers in 60 mm dishes were rinsed three times
with PBS, fixed with 3.7% paraformaldehyde in PBS at room
temperature for 10 min and incubated with X-gal staining mix
(1.5 mM MgCl2, 3.75 mM potassium ferricyanide, 3.75 mM
potassium ferrocyanide, 0.074% X-gal in PBS) for the indicated
times. Blue cells were counted under a microscope at 200-fold
magnification in twelve arbitrarily chosen fields spread evenly
over the plate.
Luciferase assays
Luciferase activity was measured using the Luciferase Assay
System (Promega) with a Spectrafluor Plus fluorometer
according to the manufacturer's instructions.
Flow cytometry
LMH cells were transfected with P expression vectors and
pCMV-GFP to permit identification of transfected cells. One,two and three days later, cell monolayers were rinsed once with
PBS and the cells were released from the plate by trypsinization.
Cells were collected, washed twice and suspended in PBS. Flow
cytometry detecting GFP fluorescence was conducted at the
Flow Cytometry Core Facility at Saint Louis University School
of Medicine. Over 50,000 cells were counted for each sample.
Northern and Western blot analyses
RNA was isolated from transfected cells employing Tri-
Reagent (Molecular Research Center). Northern blots were
performed as described previously (Tavis and Ganem, 1996)
and probed with 32P-labeled DHBVor lacZ DNA. RNAs were
detected and quantitated by phosphorimage analysis employing
a Storm Phosphorimager (Molecular Dynamics). Western blots
were performed on whole-cell lysates as described earlier (Yao
and Tavis, 2003). P was detected with mAb11 (Yao et al., 2000),
and C was detected with a rabbit polyclonal anti-C antibody.
Statistical analyses
All analyses employed one-way ANOVA post hoc tests and
were performed with SPSS software. Statistical significance
was defined as P < 0.05.
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